AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis

NCT03718143 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Safety concerns

Conditions

Myelofibroses
Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: Combination AZD1775 with AraC
DRUG: AZD1775 only

Sponsor

NYU Langone Health